C-MAF inhibitors (Boston Life Sciences/Pfizer)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameC-MAF inhibitors (Boston Life Sciences/Pfizer)
Drug Alias Nametranscription factor inhibitors (Boston Life Sciences/Pfizer)
ClassificationBiologics
Mechanisms of ActionTranscription factors inhibitors
TargetsTranscription factors
Therapy Area/IndicationsHypersensitivityAutoimmune DiseasesAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlseres Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncAlseres Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHypersensitivityAutoimmune DiseasesAsthma

Other Information

ATC CodeN/A
Related LinksN/A